Voyager Therapeutics Overview
Voyager Therapeutics Discounted Cash Flow
DCF Analysis for VYGR.
Get informed when a big investor buys or sells
+ FollowFair Value
$-3.44
Current Fair Value
$-3.44
↓ 194.7% Downside
Overvalued by 194.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison